SANA Sana Biotechnology, Inc.: Prakiraan rega marang bathi

Logo korporat perusahaan Sana Biotechnology, Inc. (SANA)

Sana Biotechnology creates hypoimmune cells for rejection-free transplants within a high scientific risk zone. The company's forward P/E valuation trend helps hedge risks, with the parameter reaching 0.00. Patents for "invisible" cells create a powerful barrier in allogeneic therapy, while strict cryopreservation control during transport guarantees drug viability.

sana.com - Pangali mangsa ngarep rega marang bathi SANA (periode 04.07.2022 - 14.11.2026)

Ringkesan rincian data analitis sana.com (SANA)

- kuotasi lan prakiraan analis:
Rega saham Sana Biotechnology Inc|SANA - Rentang target analis
- data kapitalisasi saham perusahaan:
Biji pasar Sana Biotechnology Inc|SANA - Total Nilai Perusahaan
- statistik nilai buku emiten:
Nilai Akuntansi saben Saham Sana Biotechnology|SANA - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku sana.com|SANA - Gunggung Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Sana Biotechnology|SANA - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Sana Biotechnology, Inc.|SANA - Utang perusahaan|Rasio utang marang kapitalisasi buku Sana Corp|SANA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Sana Biotechnology|Rasio cepet sana.com
- rincian asil keuangan lan kelipatan valuasi:
SANA - Bathi resik taunan|Proyeksi bathi mangsa ngarep Sana Biotechnology|SANA - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Sana Biotechnology, Inc.|SANA - Rasio P/E diaturake wutah|Pangali EV/EBITDA Sana Biotechnology Inc|SANA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Sana Biotechnology|SANA - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan sana.com|SANA - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Sana Biotechnology
- informasi babagan volume dodolan lan pendapatan:
SANA - Pendapatan dodolan perusahaan|Prakiraan volume dodolan sana.com|SANA - Rega marang dodolan|Rasio rega marang prakiraan pendapatan Sana Biotechnology
Analisis umum perusahaan:SANA Sana Bio
Produk merek Sana Biotechnology

Sana Biotechnology (SANA) is a high-tech biotech asset with a capital-intensive development model. The trend in the company's forward P/E ratio reflects market expectations regarding future earnings. This multiple compares the business's market value with the expected earnings per share. Outsourcing production and research reduces operating expenses, directly impacting the calculated yield. The stability of this indicator confirms the fundamental resilience of the company's strategy.

Perusahaan pesaing

Pangali Forward P/E LEGN|Autolus Therapeutics (AUTL) - Pangali forward rega marang bathi|Allogene Therapeutics, Inc. - Prakiraan rega marang bathi|Cartesian Therapeutics, Inc. (RNAC) - Rasio prakiraan rega marang bathi|CLLS: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRBU (Caribou Biosciences, Inc.)|TIL: Pangali Forward P/E|Prakiraan rega marang bathi Genenta Science SpA|IPSC (Century Tx) - Pangali Forward P/E|Rasio prakiraan rega marang bathi jaspertherapeutics.com JSPR|Rega marang bathi mangsa ngarep Senti Biosciences (SNTI)|Rega marang bathi mangsa ngarep ADAP (Adaptimmune Therapeutics plc)|Rega marang bathi mangsa ngarep CERo Therapeutics Holdings Inc. CERO|alaunos.com - Rega marang bathi mangsa ngarep|ACHL: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRGX (CARGO Therapeutics)|PSTX: Pangali Forward P/E|Pangali forward rega marang bathi 2seventy bio TSVT|GRCL (gracellbio.com) - Pangali Forward P/E